References
- Ray A, Huisman MV, Tamsma JT, Research and Writing-group, van Asten J, Bingen BO, Broeders EA, Hoogeveen ES, van Hout F, Kwee VA, et al. The role of inflammation on atherosclerosis, intermediate and clinical cardiovascular endpoints in type 2 diabetes mellitus. Eur J Intern Med 2009; 20: 253–260
- Averill MM, Bornfeldt KE. Lipids versus glucose in inflammation and the pathogenesis of macrovascular disease in diabetes. Curr Diab Rep 2009; 9: 18–25
- Grant PJ. Diabetes mellitus as a prothrombotic condition. J Intern Med 2007; 262: 157–172
- Natarajan A, Zaman AG, Marshall SM. Platelet hyperactivity in type 2 diabetes: Role of antiplatelet agents. Diab Vasc Dis Res 2008; 5: 138–144
- Michno A, Skibowska A, Raszeja-Specht A, Cwikowska J, Szutowicz A. The role of adenosine triphosphate citrate lyase in the metabolism of acetyl coenzyme a and function of blood platelets in diabetes mellitus. Metabolism 2004; 53: 66–72
- Lunkes GI, Lunkes DS, Leal D, Araújo Mdo C, Corrêa M, Becker L, Rosa CS, Morsch VM, Schetinger MR. Effect of high glucose levels in human platelet NTPDase and 5′-nucleotidase activities. Diabetes Res Clin Pract 2008; 81: 351–357
- Duchen MR. Roles of mitochondria in health and disease. Diabetes 2004; 53: S96–S102, Suppl 1
- Leaver HA, Schou AC, Rizzo MT, Prowse CV. Calcium-sensitive mitochondrial membrane potential in human platelets and intrinsic signals of cell death. Platelets 2006; 17: 368–377
- Edbrandt CM, Murphy S. Adenine and guanine nucleotide metabolism during platelet storage at 22°C. Blood 1990; 76: 1884–1892
- Xu J, Shi C, Li Q, Wu J, Forster EL, Yew DT. Mitochondrial dysfunction in platelets and hippocampi of senescence-accelerated mice. J Bioenerg Biomembr 2007; 39: 195–202
- Perrotta PL, Perrotta CL, Snyder EL. Apoptotic activity in stored human platelets. Transfusion 2003; 43: 526–535
- Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, Ramírez C, Sabaté M, Jimenez-Quevedo P, Hernández R, Moreno R, Escaned J, Alfonso F, et al. Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatment. Diabetes 2005; 54: 2430–2435
- Razmara M, Hjemdahl P, Ostenson CG, Li N. Platelet hyperprocoagulant activity in Type 2 diabetes mellitus: Attenuation by glycoprotein IIb/IIIa inhibition. J Thromb Haemost 2008; 6: 2186–2192
- Michno A, Bielarczyk H, Pawełczyk T, Jankowska-Kulawy A, Klimaszewska J, Szutowicz A. Alterations of adenine nucleotide metabolism and function of blood platelets in patients with diabetes. Diabetes 2007; 56: 462–467
- Skibowska A, Raszeja-Specht A, Szutowicz A. Platelet function and acetyl-coenzyme A metabolism in type 1 diabetes mellitus. Clin Chem Lab Med 2003; 41: 1136–1143
- Heptinstall S, Johnson A, Glenn JR, White AE. Adenine nucleotide metabolism in human blood–important roles for leukocytes and erythrocytes. J Thromb Haemost 2005; 3: 2331–2339
- Michno A, Raszeja-Specht A, Jankowska-Kulawy A, Pawelczyk T, Szutowicz A. Effect of L-carnitine on acetyl-CoA content and activity of blood platelets in healthy and diabetic persons. Clin Chem 2005; 51: 1673–1682
- Lunkes GI, Lunkes D, Stefanello F, Morsch A, Morsch VM, Mazzanti CM, Schetinger MR. Enzymes that hydrolyze adenine nucleotides in diabetes and associated pathologies. Thromb Res 2003; 109: 189–194
- Spanevello RM, Mazzanti CM, Maldonado PA, Zanin R, Morsch A, Hannel L, Mazzanti A, Festugatto R, Graça D, Schmatz R, et al. NTPDase and 5′-nucleotidase activities in rats with alloxan-induced diabetes. Diabetes Res Clin Pract 2004; 65: 1–6
- Miron VR, Bauermann L, Morsch AL, Zanin RF, Corrêa M, da Silva AC, Mazzanti C, Morsch VM, Lunkes GI, Schetinger MR. Enhanced NTPDase and 5′-nucleotidase activities in diabetes mellitus and iron-overload model. Mol Cell Biochem 2007; 298: 101–107
- Leal CA, Schetinger MR, Leal DB, Bauchspiess K, Schrekker CM, Maldonado PA, Morsch VM, da Silva JE. NTPDase and 5′-nucleotidase activities in platelets of human pregnants with a normal or high risk for thrombosis. Mol Cell Biochem 2007; 304: 325–330
- Verhoeven AJ, Verhaar R, Gouwerok EG, de Korte D. The mitochondrial membrane potential in human platelets: A sensitive parameter for platelet quality. Transfusion 2005; 45: 82–89
- Boudina S, Sena S, O'Neill BT, Tathireddy P, Young ME, Abel ED. Reduced mitochondrial oxidative capacity and increased mitochondrial uncoupling impair myocardial energetics in obesity. Circulation 2005; 112: 2686–2695
- Boudina S, Sena S, Theobald H, Sheng X, Wright JJ, Hu XX, Aziz S, Johnson JI, Bugger H, Zaha VG, et al. Mitochondrial energetics in the heart in obesity-related diabetes: Direct evidence for increased uncoupled respiration and activation of uncoupling proteins. Diabetes 2007; 56: 2457–2466
- Friederich M, Fasching A, Hansell P, Nordquist L, Palm F. Diabetes-induced up-regulation of uncoupling protein-2 results in increased mitochondrial uncoupling in kidney proximal tubular cells. Biochim Biophys Acta 2008; 1777: 935–940
- Bugger H, Boudina S, Hu XX, Tuinei J, Zaha VG, Theobald HA, Yun UJ, McQueen AP, Wayment B, Litwin SE, et al. Type 1 diabetic akita mouse hearts are insulin sensitive but manifest structurally abnormal mitochondria that remain coupled despite increased uncoupling protein 3. Diabetes 2008; 57: 2924–2932
- Herlein JA, Fink BD, O'Malley Y, Sivitz WI. Superoxide and respiratory coupling in mitochondria of insulin-deficient diabetic rats. Endocrinology 2009; 150: 46–55
- Maassen JA, Romijn JA, Heine RJ. Fatty acid-induced mitochondrial uncoupling in adipocytes as a key protective factor against insulin resistance and beta cell dysfunction: A new concept in the pathogenesis of obesity-associated type 2 diabetes mellitus. Diabetologia 2007; 50: 2036–2041